How many will loose jobs if the Allergan takeover does hot go through

First of all: Listen everyone working for Valeant and Mike Pearson. Eventually, you will be used up and thrown out without ceremony or praise. Valeant and Mike Pearson will heap work on you that 10 people cannot finish and then threaten to fire you if you do not complete it.

Second: If you think your job is safe, then you are an idiot. Valeant is a paper company only. A figment of financial imagination. Mike Pearson purchases companies, dismantles them, firing everyone involved, and heaping the work on other employees. This has happened time and time and time and time and time and time and time again. Get the picture? I appreciate your thoughts, however, you are not valued, you are not appreciated, and you are not worthy. Mike Pearson does not care about you. As long as he can support his business model and dupe the FDA and IRS into thinking he is a businessman, he will continue to spread heartache and pain in all employees associated with him.

Third: I was there in 2008 when Mike Pearson came on board and lied to all of our faces in a meeting when he said that our jobs were safe. That we were valued and that our purpose was to help others. Then, less than 6 weeks later, all of us were laid off...doctors, nurses, PhDs, administrators. It was a royal slap in the face.

So, for the 10 to 15 companies since 2008 that Mike Pearson has purchased and purged, I ask you: When are you going to wake up and smell the pharma? When are you going to stop seeing that there is hope. Get out now. You will be destroyed without even the littlest bit of thought. Stop beine naive and start accumulating material to sent to the FDA and IRS. This is the only way to stop the fat pig Mike Pearson.

Good luck and I hope you all land on your feet. Try not to take it so personally. Although it is personal, I must admit. Try and walk way with your head high and proud of your accomplishments within Valeant (although they will never be acknowledged). Know that KARMA will one day rear it's ugly head and land on top of Mike Pearson and his cronies. After all, who ever heard of a consultant being names President of a pharma company? What does Pearson know about pharma?

 

Bravo!

This is what's about to happen

Fatman buys often successful companies, for what is already in their pipelines. But in the case
Of Allergan it DID NOT happen

He then runs off the most talented people with layoffs, and cannot understand when the pipelines he buys go dead. Certainly, nothing new can be added to his pipelines under his lean management- people are to busy with the workload to be able to think, and be creative.

He thinks he's retaining the best, every time he has a layoff. What actually happens is that he lays off people who don't fit his preconceptions. Those layoffs in turn drive away the truly talented people who are the future of the pipeline- they leave voluntarily, because they are so good they can always find jobs elsewhere. The people that remain are kept too busy to do anything creative. The pipeline goes dead- and then he purges the rest due to "lack of performance", or "failure to execute perfectly".

 

Valeant hasn't made any big acquisition for over a year. They need to buy something of decent size to keep up the accounting tricks. The next few quarters' results will be very interesting. Meanwhile to stay alive the company will have to do the corporate equivalent of drinking your own piss and cut whatever that costs money.

 

Vicki Bryan of Gimme Credit said the often nasty battle for Allergan has exposed questions about Valeant's business model that could haunt efforts to land future large deals.

"The problematic part of their story persists and the main thrust of their highly touted business strategy to buy their way to victory continues to lose credibility," she said in an interview.

The corporate bond analyst criticizes Valeant's "very opaque numbers" which hide its real organic growth. It's the same complaint levelled by Allergan, which accused Valeant of relying on more than 100 acquisitions since 2008 to fuel its growth and by using price increases to camouflage what it claimed were weak increases in organic sales.

Valeant has called those allegations "baseless."

In addition to concerns about the quality of Valeant's core operating trends, Bryan said Valeant faces lawsuits and regulator probes on alleged insider trading in Allergan.

 

What lies ahead: Targets not reached for Q4 and into 2015. No growth shown across the company & managers heads on the line = get rid of the underachievers. Plus any other available excuses just to get rid of people. Oh yeah

 

Scary times ahead!

 

Indeed!

 

Shares down today big time

 

Hey losers ask someone how big Q3 payouts were in Derm- thats right huge. kiss it jackasses

 

Facts won't get in their way of hate for Valeant.

 

No one disputes that Valeant focuses on sales. people who sell tons of shit will get big bonus. No one disputes that Valeant makes money from selling drugs , because duh that is the only thing they committed to do. If you could stop being so myopic and look at the big picture , you will see that you won't be able to sell for valeant in a couple of years since nobody at Valeant develop new things for you to sell. Then again , maybe you don't care and your plan is to move on to the next company that needs people to sell their stuffs.

 

For growth (new products), you can spend money on either R&D or acquisitions. Pearson believes that the return on investment (ROI) is better with acquisitions. So don't expect Valeant to spend much on R&D.

 

Yeah well we have NO R&D & he just missed his golden ticket AGN so now we got jackshit! Not to mention the $16 billion in debt we're carrying
Woooops, sinking ship I hear you say..

 

There is no shortcut in research&development. Valeant does not have the capacity OR expertise for even the late stage development so they can't help small Pharma realize the value of their pipeline. What Valeant needs are products that are ready to be approved. But for those products the target company would rather move forward independently unless they are in dire financial situation. It has been shown in the Allergan saga that companies can and will resist Valeant's advance. The Ackman trick has already been played and there will be no element of surprise next time around. There are limited number of non-turd companies that Valeant can buy in the future. What Valeant promised to the investors is essentially that they are astronomically better in selling drugs than other people because they barely have any resource and money to do anything else . Maybe that is true, maybe not. You vote with your own money.

 

Great summary! Straight to the heart of the matter.

 

I'll second that, very well said!
But I very much doubt that they can sell products without the backing of some type of resources & this already has been proven in parts of Europe, where they are witnessing zero growth or negative growth. This will only get worse!!!!!!!!

 

Holy shit another approval today- this company has no R&D- what? We own Derm face it

 

To Numbnut " we own Derm"

This revamp of an existing product is going to be the next Lipitor. Once you convince managed care that this "in between" strength is anything more than a marketing ploy and once physicians are convinced it makes any sense to write you will certainly need to hire a specialized sales force for this. Only to shut it down three months later when nobody's buying this story. #typicalvaleantfail

 

#37
Old Today, 11:08 AM
Anonymous


Holy shit another approval today- this company has no R&D- what? We own Derm face it

Lol... Holy shit ,with a idiot like you we are truly " fucked" ...doh...

 

I will sell cat shit if I can keep on doing 250K per year, you are jealous with your 5 k per quarter bonus checks and that is a fact, sucker